Tag Archive > Chronic Kidney Disease

Cartoon cat Garfield’s Mid-Life Crisis Sheds Light on the Danger of Cat Kidney Disease

Monheim, Germany (ots/PRNewswire) – A new campaign launched today will educate cat owners about the risk of chronic kidney disease (CKD) that their pets may face as they grow older and urge them to seek kidney function tests for cats over the age of seven. A brand new animation featuring Garfield (as licensed by Paws [...]

Continue reading

, , , , , , , , , , , , , , , , , , ,

XLVIII ERA-EDTA Congress in Prague from 23 June to 26 June 2011

Prag (ots) – The congress of the ERA-EDTA (European Renal Association and European Dialysis and Transplant Association) is the biggest congress in Europe on nephrology and renal replacement therapy. You are cordially invited to attend this Congress. The Opening Press Conference will be held on Thursday 23rd June, 11 am (Corinthia Hotel). Topic: Can the [...]

Continue reading

, , , , , , , , , , , , , , , , , , ,

Chronic Kidney Disease and Cardiovascular Risk

Strasbourg, France (ots/PRNewswire) – The European Kidney Health Alliance (EKHA) and World Kidney Day (WKD) organisations today call for urgent European Union (EU) action to curb the increasing burden of chronic kidney disease (CKD) and associated diseases. The Members of European Parliament (MEP) Group for Kidney Health met with some of Europe’s top kidney experts [...]

Continue reading

, , , , , , , , , , , , , , , , , , ,

SHARP-Studie bei Patienten mit chronischer Niereninsuffizienz / Signifikante Reduktion der kardiovaskulären Ereignisse durch Ezetimib/Simvastatin

Haar (ots) – Die duale Cholesterinhemmung mit dem Cholesterinresorptionshemmer Ezetimib und Simvastatin (INEGY®) konnte bei Patienten mit chronischer Niereninsuffizienz das Risiko für schwerwiegende vaskuläre Ereignisse signifikant senken. Dieses Ergebnis der Endpunktstudie SHARP (Study of Heart And Renal Protection), wurde auf Jahrestagung der American Society of Nephrology, von den Hauptstudienleitern Prof. Colin Baigent und Dr. Martin [...]

Continue reading

, , , , , , , , , , , , , , , , ,

Good News for Kidney Patients: World’s Largest Kidney Disease Trial Shows Big Benefits From Reducing Cholesterol

Denver, November 20 (ots/PRNewswire) – Around a quarter of all heart attacks, strokes, and operations to open blocked arteries could be avoided in people with chronic kidney disease by using the combination of ezetimibe and simvastatin to lower blood cholesterol levels. That’s the conclusion from the world’s largest ever randomized trial in kidney disease. Unveiling [...]

Continue reading

, , , , , , , , , , , , , , , , , , ,

Results From Study of Vascular Calcification in Dialysis Patients Presented in Late-Breaking Clinical Trial Session at ERA-EDTA 2010 Congress

Munich, June 26, 2010 (ots/PRNewswire) – Results from the ADVANCE study presented in a late breaking clinical trial session at the ERA-EDTA 2010 Congress provide new insights into the management of secondary hyperparathyroidism (SHPT) in chronic kidney disease (CKD) patients. ADVANCE (A randomiseD VAscular calcificatioN study to evaluate the effects of CinacalcEt) is a randomised, [...]

Continue reading

, , , , , , , , , , , , , , , , , , ,

Chronic Kidney Disease and Diabetes – Major Risk Factors Amongst Europe’s Population to Be Urgently Addressed

Strasbourg, France, March 10, 2010 (ots/PRNewswire) – The European Kidney Health Alliance (EKHA) and World Kidney Day (WKD) organisations today call for European Union (EU) support. Early awareness, identification and treatment of chronic kidney disease (CKD) and its associated diseases, including diabetes – the leading cause of CKD(1) – must be prioritised on the EU [...]

Continue reading

, , , , , , , , , , , , , , , , , , ,

New Findings Provide Additional Insights into the Management of Anaemia and Secondary Hyperparathyroidism in Chronic Kidney Disease Patients

Milan (ots/PRNewswire) – Data presented from large-scale observational studies provide new insights into the day-to-day management of two major complications of CKD: anaemia and secondary hyperparathyroidism (SHPT).(1), (2), (3), (4) – CKD anaemia: Aranesp(R) (darbepoetin alfa) flexible dosing intervals help maintain haemoglobin (Hb) levels within the target range for dialysis and pre-dialysis patients, while offering [...]

Continue reading

, , , , , , , , , , , , , , , , , , ,

Chronic Kidney Disease and Hypertension: Twin Challenges for 21st Century Europe

Strasbourg, France (ots/PRNewswire) – – Meeting at European Parliament relays stark message and calls for action to support early identification and treatment of CKD, especially among patients at greatest risk The European Kidney Health Alliance (EKHA) and World Kidney Day (WKD) organisations today call for action at EU level to support early awareness, identification and [...]

Continue reading

, , , , , , , , , , , , , , , , , , ,

First Study in Real-Life Setting Confirms That Once-Monthly Mircera Keeps Haemoglobin Levels Within a Tight Range

Basel, Switzerland, November 10 (ots/PRNewswire) – – Results Demonstrate Effective and Simplified Approach to Anaemia Management in Chronic Kidney Disease Patients on Dialysis Interim study results from 90 renal centres in Germany confirm for the first time that in a real-life setting Mircera(R) maintains haemoglobin (Hb) levels within a narrow range when chronic kidney disease [...]

Continue reading

, , , , , , , , , , , , , , , , , ,